Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence

  • Han, Sangbin
  • Yang, Ju Dong
  • Sinn, Dong Hyun
  • Ko, Justin Sangwook
  • Kim, Jong Man
  • ... Son, Hee Jeong
  • 외 4명
Citations

WEB OF SCIENCE

8
Citations

SCOPUS

11

초록

Background Serum bilirubin level, which may reflect the host defense against increased oxidative stress, is inversely associated with the risk of cancer development. In liver transplantation, the intrinsic bilirubin metabolism of donor liver is subsequently translated into recipient. Thus, we hypothesized that liver transplantation conducted with living donors with higher serum bilirubin reduces hepatocellular carcinoma (HCC) recurrence. Methods Two hundred fifty recipients who underwent liver transplantation for treating HCC within the Milan criteria were included in the study. The association between donor preoperative total bilirubin concentration and the risk of HCC recurrence was analyzed using the Fine and Gray regression model with posttransplant death as a competing risk event with adjustment for tumor biology including -fetoprotein, histological differentiation, and microvascular invasion. Results All donors were confirmed to have no underlying hepatobiliary diseases or hematological disorders. Donor preoperative total bilirubin concentration was 0.7 mg/dL in median and ranged from 0.2 to 2.7 mg/dL. Thirty-five (14.0%) recipients developed HCC recurrence. Multivariable analysis demonstrated that donor preoperative total bilirubin concentration was inversely associated with the recurrence risk (hazard ratio, 0.22; 95% confidence interval, 0.07-0.72; P = 0.013). The highest (1.0 mg/dL) versus lowest (0.6 mg/dL) tertile of donor preoperative total bilirubin showed a significant reduction of the recurrence risk (hazard ratio, 0.28; 95% confidence interval, 0.11-0.70; P = 0.006). Conclusions Hepatocellular carcinoma recurrence risk decreases in relation to the increase in total serum bilirubin level of healthy living donors without underlying hepatobiliary or hematological disorders. Further validation of bilirubin as a potent anticancer substance against HCC is warranted.

키워드

GILBERTS-SYNDROMESERUM BILIRUBINUNCONJUGATED HYPERBILIRUBINEMIATHERAPEUTIC APPLICATIONSCOMPETING RISKSTRANSPLANTATIONMICROSTEATOSISANTIOXIDANTPOPULATIONBILIVERDIN
제목
Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence
저자
Han, SangbinYang, Ju DongSinn, Dong HyunKo, Justin SangwookKim, Jong ManShin, Jun ChulSon, Hee JeongGwak, Mi SookJoh, Jae-WonKim, Gaab Soo
DOI
10.1097/TP.0000000000001293
발행일
2016-09
유형
Article
저널명
Transplantation
100
9
페이지
1933 ~ 1938